Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

NEW
STU:4E2 (USA)  
€ 4.34 -0.22 (-4.82%) Jul 20
At Loss
P/B:
2.40
Market Cap:
€ 460.50M ($ 525.10M)
Enterprise V:
€ 255.05M ($ 290.83M)
Volume:
0
Avg Vol (2M):
1.87K
Trade In:

Relmada Therapeutics Inc Valuation Measures